Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why limit any calculations to 100k treatments a month. If the product works then worldwide demand will be phenomenal. When daily cases are reaching almost 600k across the globe then no doubt the company will have to consider taking up production to a minimum of 500k treatments a month.
Well done everyone ! So much positivity on this Saturday morning. The info hounds have excelled themselves once again with the quality of information on here. Cracking work you lot. :-) GLA as this promises to be the start of an exciting month.
Sorry Derek! No idea who you are. 'Consider'. Predictivevtext whilst queuing to pick up other hall's order before we're not allowed out
There are so many variables to consiDerek but share value wise the likelihood of another complete lockdown here, France and Germany just adds more value if you have an effective treatment. And whilst we believe it is, the next couple of months should confirm it. Definitely more than £1.66.....
£100 a share should see me mortgage free and a bit left over in the bank.
I just feel that things like that don't happen to me! I will have to lie to my wife and say I got twice as much though as she isn't fully aware of how much I have invested!!
My target here is £20/share. That is working on a figure of 500p per billion mkt cap.
It is very rare that you find a company with so few shares yet with so much potential. I'm hoping that someone finally see's sense and pushes SNG into every hospital in the land to save lives. Far too many are dying and they could be saved.
My dream is a mkt cap of 10bn or £100/share and the scary thing is that that is possible here.
Great Saturday thread! I like to go back to what value is in RM’s head as he is the one negotiating. The only clue we have is the Shares magazine presentation he did in 2016. He cited other biotech takeover and how the value increased with successful stage of development.
Phase 1 - buyout for $225m
Phase 2 - buyout $1.25bn
Phase 3 - a 2014 Roche buyout for $8bn
So we are potentially benchmarking at p2 now, so c.£6 a share. With successful phase 3, we could be up to £40 a share.
And those figures were at least 6 years old and didn’t refer to the first effective drug in a global pandemic infecting over 30m people and torpedoing economies.
In RM’s own words:
“What we have with interferon beta is an asset that can be worth lots of money, so that we provoke some sort of event like this” [These takeover numbers]
If you haven’t watched this video before it is well worth a look as an insight into RM’s thinking and how he describes the SNG commercial strategy. The man knows what this is worth.
Valuations are at 13min30
https://m.youtube.com/watch?v=BzK7lCjN6Jw
£4 isn't really based on anything in particular to be honest. Just it would show a nice wee profit in my IG account and I could see my fingers getting twitchy and withdrawing some of that.
I do think that target will be revised as more news comes out. Maybe I am just naturally quite cautious and don't believe I would be lucky to stumble across an investment like this which of it did end up at £40 or £50 would be genuinely life changing.
I say all that, but then I read the links and if things do go well in phase 3, which the seems promosing, there is no reason why this wouldn't just take off.
I also factor in the broker targets...the 990p included a proportion of downside which assumed it didn’t make it to market - so if you are confident it does then the price should be double digits at least. That is my first target for a small sale. Then hold the rest until commercial partner / takeover at which point £4-5bn MCap does not sound crazy, or £20-25. Could higher as the upside broker note suggested.
Don’t forget licensing deals. Synairgen’s income is not limited to just what it can produce, the greater value comes from owning that patent.
BOJO - I agree with everything your saying. Potentially the value of this drug is almost incomprehensible just now. If this really can save hundreds of thousands of lives and keep people off be dilators, maybe even out of hospital altogether, then £10 is nowhere near enough.
Targets may change depending on what happens but in the short term if we can hit those £4 and £10 numbers then I will be happy. Will Keep re-evaluating as we go though.
The company is building itself into an excellent position and one which it can negotiate from strongly.
Assuming P3 confirms that we know already, works for CoVID and is safe and can be used with steroids.
Plus we are already on track for £1.2bn revenues for 2021, I can’t see why our MCap would get to a minimum, minimum of £5bn (=£25 per share), and frankly if we get bought out in a bidding war, the. £10bn MCap is easily attainable.
I like those numbers matt
I think it is worth bearing in mind the rise of NCYT. Also understanding the catalysts for the increased SP. Basically £70 million in May 2020 (UK Gov). £230 million in September 2020 (UK GOV) and the possibility of another order in excess of £230 million. I presume you all know that NCYT has gone from 6p to £12.00 in one year. So the question is, what will be the driving factor for an increase in SP for SNG?
In the first instance the biggest gain was due to the amazing phase 2 trial. Clearly phase 3 or emergency use, peer reviews, FDA or and CE approval will all add value. What I am saying is don't just think of a figure like £4 or £20.00. Try and figure how much value will be added along the way...
Oh and I have not even considered monetisation. With any or all of the above this will continue to add value, especially when the contracts start being signed and the money rolls in.
CR1909 personal I think you would be crazy to bail at 400. I’m holding out until we get to market or we are bought out. Minimum for either of those will be 800 and could be substantially higher. Rather than sell out in one go the best option with a share like this is to top skim 10 or 20 percent on the peaks after news.
Hi CR,
Whats 400p based on? For me when the picture becomes a little clearer with regards to revenue/profit numbers we can revaluate a fair price. There are people on here far smarter than me who are good at breaking it all down.
Remember with the new shares in issue (200m total) means, for example, an mcap of 1bn is now 500p instead of 615p-ish
50 quid and not a penny less...........................
Since things tend to be a bit quieter on a Saturday, thought I would post something slightly off topic.
First up, this isnt asking for estimates of what people think is realistic and people shouldn't be influenced by any of the replies here, but:
What price are you holding out for before you sell?
There are still so many variables which could affect us. My average is 1.63 and realistically if the SP goes near 400p I may struggle not to sell. I guess it will likely depend on what the news is that has led to that increase though. Anything beyond 1000 and I am starting to get into dreamland.
If thi